Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer

References

• NICE guideline [NG12]. Suspected cancer: recognition and referral; Published date June 2015 [updated 2017 July; cited 2018 May]. Available from: https://www.nice.org.uk/guidance/ng12 .
   Google Scholar
• NICE Diagnostics guidance [DG30]. Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care; Published date July 2017 [cited May 2018]. Available from: https://www.nice.org.uk/guidance/dg30.
   Google Scholar
• National Cancer Intelligence Network. Routes to Diagnosis 2006–2013 workbook (a). London: NCIN; 2015. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence
   Google Scholar
• Turvill J, Aghahoseini A, Sivarajasingham N, et al. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study. Br J Gen Pract. 2016;66:e499–506.
   PubMed Web of Science ®Google Scholar
• Rubeca T, Cellai F, Confortini M, et al. Impact of preanalytical factors on fecal immunochemical tests: need for new strategies in comparison of methods. Int J Biol Markers. 2015;30:e269–e274.
   PubMed Web of Science ®Google Scholar
• Fraser CG, Halloran SP, Allison JE, et al, for the STARD Group. A standard for faecal immunochemical tests for haemoglobin evaluation reporting (FITTER). Ann Clin Biochem. 2014;51:301–302.
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, et al, for the STARD Group. STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies. Clin Chem. 2015;61:1446–1452.
   Google Scholar
• Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–662.
   PubMed Web of Science ®Google Scholar
• Westwood M, Lang S, Armstrong N, et al. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Medicine. 2017;15:189.
   PubMed Web of Science ®Google Scholar
• Widlak M, Thomas C, Thomas M, et al. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients. Aliment Pharmacol Ther. 2017;45:354–363.
   PubMed Web of Science ®Google Scholar
• McDonald PJ, Digby J, Innes C, et al. Low faecal haemoglobin concentration potentially rules out significant colorectal disease. Colorectal Dis. 2013;15:e151–e159.
   PubMed Web of Science ®Google Scholar
• Mowat C, Digby J, Strachan J, et al. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms. Gut. 2016;65:1463–1469.
   PubMed Web of Science ®Google Scholar
• Högberg C, Karling P, Rutegård J, et al. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study. Scand J Gastroenterol. 2017;52:69–75.
   PubMed Web of Science ®Google Scholar
• Cubiella J, Salve M, Díaz-Ondina M, et al. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients; comparison with NICE and SIGN referral criteria. Colorectal Dis. 2014;16:273–282.
   PubMed Web of Science ®Google Scholar
• Young GP, Symonds EL, Allison JE, et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci. 2015;60:609–622.
   PubMed Web of Science ®Google Scholar
• Auge J, Fraser C, Rodriguez C, et al. Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients. Clin Chem Lab Med. 2016;54:125–132.
   PubMed Web of Science ®Google Scholar
• Kapidzic A, van Roon A, van Leerdam M, et al. Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer. Gut. 2015;66:118–123.
   PubMed Web of Science ®Google Scholar
• Högberg C, Söderström L, Lilja M. Faecal immunochemical tests for the diagnosis of symptomatic colorectal cancer in primary care: the benefit of more than one sample. Scand J Prim Health Care. 2017;35:369–372.
   PubMed Web of Science ®Google Scholar
• McDonald PJ, Strachan JA, Digby J, et al. Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer. Clin Chem Lab Med. 2012;50:935–940.
   Web of Science ®Google Scholar
• Cubiella J, Vega P, Salve M, et al. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients. BMC Med. 2016;14:128. DOI 10.1186/s12916-016-0668-5
   PubMed Web of Science ®Google Scholar
• Cubiella J, Digby J, Rodriguez-Alonso L, et al. The fecal hemoglobin concentration, age and sex test score: development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients. IJC. 2017;140:2201–2211.
   Google Scholar
• Turvill JL, O’Connell S, Brooks A, et al. Evaluation of a faecal calprotectin care pathway for use in primary care. PCRD. 2016;17:428–436.
   Google Scholar
• Kok L, Elias S, Witteman B, et al. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the cost-effectiveness of a decision rule for abdominal complaints in primary care (CEDAR) study. Clin Chem. 2012;58:989–998.
   PubMed Web of Science ®Google Scholar
• Elias S, Kok L, de Wit N, et al. Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study. BMC Med. 2016;14:1–11.
   PubMed Web of Science ®Google Scholar
• Kim B, Joo J, Chang H, et al. A predictive model combining fecal calgranulin B and fecal occult blood tests can improve the diagnosis of colorectal cancer. PLoS One. 2014;9:e106182.
   PubMed Web of Science ®Google Scholar
• Parente F, Marino B, Ilardo A, et al. A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study. Eur J Gastroenterol Hepatol. 2012;24:1145–1152.
   PubMed Web of Science ®Google Scholar
• Shin H, Suh M, Baik H, et al. Performance of the faecal immunochemical test for colorectal cancer screening using different stool collection devices: preliminary results from a randomized controlled trial. Gut and Liver. 2016;10:925–931.
   PubMed Web of Science ®Google Scholar
• Mellen S, de Ferrars M, Chapman C, et al. Evaluation of sample stability for a quantitative faecal immunochemical test and comparison of two sample collection approaches. Ann Clin Biochem. 2018;55:657–664.
   PubMed Web of Science ®Google Scholar
• Young GP, Sinatra MA, St John DJB. Influence of delay in stool sampling on fecal occult blood test sensitivity. Clin Chem. 1996;42:1107–1108.
   PubMed Web of Science ®Google Scholar
• Brown LF, Fraser CG. Effect of delay in sampling on haemoglobin determined by faecal immunochemical tests. Ann Clin Biochem. 2008;45:604–605.
   PubMed Web of Science ®Google Scholar
• Carroll M, Piggott C, Pearson S. et al. An evaluation of quantitative faecal immunochemical tests for haemoglobin. 2014;63(Suppl 1): PWE-019. DOI:10.1136/gutjnl-2014-307263.279
   Google Scholar
• Tappenden P, Chilcott J, Brennan A, et al. Using whole disease modeling to inform resource allocation decisions: economic evaluation of a clinical guideline for colorectal cancer using a single model. Value Health. 2013;16:542–553.
   PubMed Web of Science ®Google Scholar
• Steele RJC, Fraser CG. Faecal immunochemical tests (FIT) for haemoglobin for timely assessment of patients with symptoms of colorectal disease. In: Olsson L, editor. Timely diagnosis of colorectal cancer. Cham: Springer; 2018.
   Google Scholar
• Fraser CG. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: concepts and challenges. Surgeon. 2018;16:302–308.
   PubMed Web of Science ®Google Scholar
• Swann R, McPhail S, Witt J, et al. Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit. Br J Gen Pract. 2018;68:e63–e72.
   PubMed Web of Science ®Google Scholar